期刊
JOURNAL OF PATHOLOGY
卷 226, 期 5, 页码 713-722出版社
WILEY
DOI: 10.1002/path.3015
关键词
Notch; chemokine receptor; CCR5; CCR9; CXCR4; CCR7; CCL25; proliferation; chemotaxis; T cell acute lymphoblastic leukaemia
资金
- Milano University
- MIUR [PRIN 2008-2008ZFYEY3_003]
- Ministry of Health
- Ministry of Health, Progetti Ricerca Oncologica [RFPS-2006-4-341763, RFPS-2006-2-340145, RFPS-2006-Regione Umbria]
- Regione Lombardia
- Fondazione Policlinico S. Matteo (Progetti Ricerca Corrente)
- Associazione Italiana Ricerca sul Cancro (AIRC) [5x1000]
Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation. Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life. We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia. We inhibited the pathway through ?-Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors. Our results indicate that ?-Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered. The Notch pathway also controls CCR5- and CCR9-mediated biological effects, ie chemotaxis and proliferation. Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity. Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions. These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization. Copyright (c) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据